TREM2 and early-onset autosomal dominant Alzheimer disease: However, TREM2 p.R47H carriers had worse cognitive performance when measured by the ADAS-Cog 13 and DMS, despite none of these participants meeting the criteria for mild cognitive impairment or Alzheimer’s disease.